News

Hallucinations Are Not 'Benign' in Parkinson's Disease


 

SAN DIEGO – So-called benign hallucinations associated with dopaminergic treatment for Parkinson's disease rarely remain “benign,” calling into question the accuracy of the term.

Researchers at Rush University in Chicago studied the clinical progression of 48 patients with Parkinson's disease who were diagnosed with hallucinations characterized by the patient's retention of the insight that the hallucinations are unreal. These hallucinations have been called benign, and traditionally have been associated with a Unified Parkinson Disease Rating Scale (UPDRS) Thought Disorder score of 2.

In 2 years, just 2 of the 48 patients at Rush continued to have benign hallucinations without requiring either a decrease in their dose of dopaminergic medications or an addition of neuroleptic agents to counteract the hallucinations or progressing to more serious hallucinations with loss of insight (UPDRS Thought Disorder score of 3) or delusions (UPDRS Thought Disorder score of 4).

Most, 39 of 48, progressed to scores of 3 or 4. Among nine patients who remained at a score of 2, seven required reduced dosages of dopaminergic medications in response to worsening of hallucinations and three also required neuroleptics to control the hallucinations.

Although the median time to progression of hallucinations to the point where patients were frankly delusional was less than 2 years after the onset of the study, the total length of time patients had hallucinations prior to enrollment was uncertain, noted Dr. Christopher G. Goetz, director of the Rush movement disorders center, in a poster presentation at the annual meeting of the American Neurological Association.

However, the study made clear the fact that even if hallucinations seem “benign … at the moment,” they “portend serious consequences” and should not be given a label that suggests they are unimportant clinical developments, he said.

“Because hallucinations progress, the concept of benign hallucinations is prognostically misleading,” Dr. Goetz and associates concluded. “The term benign hallucinations should be considered generally unsound and dropped from the operative vocabulary.”

Recommended Reading

Sleep-Deprivation Regimen Brings FAST Results : Insomnia patients treated with new therapy show improved sleep latency, efficiency, and total sleep time.
MDedge Psychiatry
Jet Lag Is Avoidable Through Preflight Phase-Shifting
MDedge Psychiatry
FOUR Score Challenges Glasgow Coma Scale
MDedge Psychiatry
Novel Drug Shows Promise for Sleep Initiation, Maintenance
MDedge Psychiatry
Abundance of Insomnia Therapies in the Pipeline
MDedge Psychiatry
Home Diagnosis of Obstructive Sleep Apnea Far Less Costly
MDedge Psychiatry
Insomnia Classification Brings New Terminology
MDedge Psychiatry
Quantitative EEG Diagnostic Of Vascular Dementia Severity
MDedge Psychiatry
A ‘bad’ boy’s behavior problems
MDedge Psychiatry
Does chronic pain shrink the brain?
MDedge Psychiatry